Journal article : Letter

Does tenofovir-containing first-line antiretroviral therapy mitigate the impact of pretreatment non-nucleoside reverse transcriptase inhibitor drug resistance?

Alternative title:: Correspondence

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Inzaule, S. C., Rinke de Wit, T. F., Hamers, R. L., & to Evaluate Resistance, P.-A. S. (2018). Does tenofovir-containing first-line antiretroviral therapy mitigate the impact of pretreatment non-nucleoside reverse transcriptase inhibitor drug resistance? Clinical Infectious Diseases, 68(12), 2158–2160.

MLA Style

Inzaule, S. C., et al. “Does Tenofovir-Containing First-Line Antiretroviral Therapy Mitigate the Impact of Pretreatment Non-Nucleoside Reverse Transcriptase Inhibitor Drug Resistance?” Clinical Infectious Diseases, vol. 68, no. 12, Oxford University Press, 2018, pp. 2158–60.

Chicago Style

Inzaule, SC, TF Rinke de Wit, RL Hamers, and Pan-African Studies to Evaluate Resistance. 2018. “Does Tenofovir-Containing First-Line Antiretroviral Therapy Mitigate the Impact of Pretreatment Non-Nucleoside Reverse Transcriptase Inhibitor Drug Resistance?” Clinical Infectious Diseases 68 (12): 2158–60.
Share
Print

Access Document

Files:: CID-92626 TDF.pdf

(Preview, Accepted manuscript, 839.6KB, Terms of use)

Publisher copy:: 10.1093/cid/ciy1070

Authors

+ Inzaule, SC More by this author

Role:: Author

+ Rinke de Wit, TF More by this author

Role:: Author

+ Hamers, RL More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDM
Sub department:: Tropical Medicine
Role:: Author
ORCID:: 0000-0002-5007-7896

+ Pan-African Studies to Evaluate Resistance More by this author

Role:: Author

Publisher:: Oxford University Press
Journal:: Clinical Infectious Diseases More from this journal
Volume:: 68
Issue:: 12
Pages:: 2158-2160
Publication date:: 2018-12-18
Acceptance date:: 2018-12-13
DOI:: 10.1093/cid/ciy1070
EISSN:: 1537-6591
ISSN:: 1058-4838
Pmid:: 30561519

Language:: English
Keywords:: FFR
Subtype:: Letter
Pubs id:: 1025501
Local pid:: pubs:1025501
Deposit date:: 2020-09-02

Terms of use

Copyright holder:: Inzaule, SC et al.
Copyright date:: 2019
Rights statement:: © The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model.

Licence:: Other

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP